arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Rigel Pharmaceuticals, Inc.

RIGL Health Care Biotechnology: Pharmaceutical Preparations
$29.93
▼ -1.1% Today
as of Jun 7, 07:26 ET
Last 30 days -2.06% Apr 28 → Jun 05
$25.55 $27.32 $29.09 $30.85 $32.62 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$30.33
High
$30.69
Low
$29.74
Volume
$498,314
Avg Vol
$485,164
Mkt Cap
$556M
P/E (TTM)
5.78
Beta
52w High
$52.24
52w Low
$18.14
Div Yield
Shares Out

Overview

52-week range
$18
$52
35% of range
Avg surprise (last 2)
+154.7%
Avg reaction (last 2)
-4.7%
0% positive
Latest IV / EM
95%
EM ±13.1% · $30 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.47$0.47$1.41$2.34$3.28 Actual $-0.38Actual $-0.33Actual $-0.47Actual $-0.06Actual $0.70Actual $0.63Est $0.14Actual $3.28Actual $1.46Actual $0.44Est $0.74 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-1M$26M$53M$80M$107M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $0.44 $0.74 -40.5% -30.2% -4.9% earnings
Tue Sep 30, 2025Sep 2025 $1.46 financials
Mon Jun 30, 2025Jun 2025 $3.28 financials
Tue May 6, 2025Mar/2025 $0.63 $0.14 +350.0% -4.4% earnings
Mon Sep 30, 2024Sep 2024 $0.70 financials
Sun Jun 30, 2024Jun 2024 $-0.06 financials
Sun Mar 31, 2024Mar 2024 $-0.47 financials
Sat Sep 30, 2023Sep 2023 $-0.33 financials
Fri Jun 30, 2023Jun 2023 $-0.38 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$59M$69M$102M$53M$55M$37M
Cost of revenue$5M$5M$5M$4M$8M$3M
Gross profit
Operating income$12M$28M$61M$13M$14M$447,000
Net income$9M$28M$60M$11M$12M$-1M
EPS (diluted)$0.44$1.46$3.28$0.63$0.70$-0.06

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$24M$41M$49M$53M$46M$57M$52M$36M
Inventory$12M$12M$13M$10M$5M$6M$5M$8M
Total current assets$234M$240M$215M$175M$147M$135M$106M$95M
Total assets$505M$514M$243M$207M$176M$164M$139M$128M
Long-term debt$45M$60M$60M$60M$60M$60M
Total liabilities$105M$122M$125M$125M$157M$161M$154M$158M
Total equity$400M$391M$118M$82M$19M$3M$-15M$-30M

Implied volatility — last 90 days

89%92%94%97%99% Jun 07 — IV 95% · EM ±13.1%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.